Changing pattern of candidaemia 2001-2006 and use of antifungal therapy at the University Hospital of Vienna, Austria

Clinical Microbiology and Infection

Volumn 13, Issue 11, 2007, Pages 1072-1076

  Presterl, Elizabeth ^a   Daxbock F ^a   Graninger, W ^a   Willinger, B ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antifungal agents; Candidaemia; Drug use; Frequency; Surveillance; Therapy

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; VORICONAZOLE;

ARTICLE; AUSTRIA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA LUSITANIAE; CANDIDA SAKE; CANDIDA TROPICALIS; CANDIDEMIA; DISEASE SURVEILLANCE; DRUG USE; FUNGUS ISOLATION; HUMAN; MYCOSIS; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROEPIDEMIOLOGY; SURVIVAL RATE; TREND STUDY; UNIVERSITY HOSPITAL;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA SAKE; CANDIDA TROPICALIS; CLAVISPORA LUSITANIAE;

EID: 35148822315     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2007.01812.x     Document Type: Article

References (23)

1. Vigouroux S, Morin O, Moreau P et al. Candidemia in patients with hematologic malignancies: Analysis of 7 years' experience in a single center. Haematologica 2006; 91: 717-718.
2. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003; 3: 685-702.
3. Banerjee SN, Emori TG, Culver DH et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med 1991; 91: 86S-89S.
4. Leleu G, Aegerter P, Guidet B. Systemic candidiasis in intensive care units: A multicenter, matched-cohort study. J Crit Care 2002; 17: 168-175.
5. Sendid B, Cotteau A, Francois N et al. Candidaemia and antifungal therapy in a French university hospital: Rough trends over a decade and possible links. BMC Infect Dis 2006; 6: 80-88.
6. Viscoli C, Girmenia C, Marinus A et al. Candidemia in cancer patients: A prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 1999; 28: 1071-1079.
7. Sandven P, Bevanger L, Digranes A et al. Candidemia in Norway (1991-2003): Results from a nationwide study. J Clin Microbiol 2006; 44: 1977-1981.
8. Marchetti O, Bille J, Fluckiger U et al. Epidemiology of candidemia in Swiss tertiary care hospitals: Secular trends, 1991-2000. Clin Infect Dis 2004; 38: 311-320.
9. Bassetti M, Righi E, Costa A et al. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 2006; 6: 21-27.
10. Beck SC, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 1995; 167: 1247-1251.
11. Wingard JR, Merz WG, Rinaldi MG et al. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 325: 1274-1277.
12. Trick WE, Fridkin SK, Edwards JR et al. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 2002; 35: 627-630.
13. Abi-Said D, Anaissie E, Uzun O et al. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997; 24: 1122-1128.
14. Voss A, Kluytmans JA, Koeleman JG et al. Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals. Eur J Clin Microbiol Infect Dis 1996; 15: 909-912.
15. Ostrosky-Zeichner L, Pappas PG. Invasive candidiasis in the intensive care unit. Crit Care Med 2006; 34: 857-863.
16. Horsburgh CRJ, Kirkpatrick CH. Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: Experience with twenty-one patients. Am J Med 1983; 74: 23-29.
17. Tortorano AM, Biraghi E, Astolfi A et al. European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: Report from one Italian region. J Hosp Infect 2002; 51: 297-304.
18. Arendrup MC, Fuursted K, Gahrn-Hansen B et al. Seminational surveillance of fungemia in Denmark: Notably high rates of fungemia and numbers of isolates with reduced azole susceptibility. J Clin Microbiol 2005; 43: 4434-4440.
19. Wingard JR. The changing face of invasive fungal infections in hematopoietic cell transplant recipients. Curr Opin Oncol 2005; 17: 89-92.
20. Graninger W, Presteril E, Schneeweiss B et al. Treatment of Candida albicans fungaemia with fluconazole. J Infect 1993; 26: 133-146.
21. Voss A, de Pauw BE. High-dose fluconazole therapy in patients with severe fungal infections. Eur J Clin Microbiol Infect Dis 1999; 18: 165-174.
22. Pittet D, Monod M, Suter PM et al. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994; 220: 751-758.
23. Leon C, Ruiz-Santana S, Saavedra P et al. A bedside scoring system ('Candida score') for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 2006; 34: 730-737.